GLP-1 analogues

Details GLP-1 analogues GLP-1 analogues

2008-05-06

2008-05-06

Borin, Michael (Department: 1631)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S324000, C530S308000

Reexamination Certificate

active

09856676

ABSTRACT:
The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefor comprising said analogues.

REFERENCES:
patent: 5545618 (1996-08-01), Buckley et al.
patent: 5705483 (1998-01-01), Galloway et al.
patent: 6410513 (2002-06-01), Galloway et al.
patent: 6458924 (2002-10-01), Knudsen et al.
patent: 6620910 (2003-09-01), Calas et al.
patent: 6720407 (2004-04-01), Hughes et al.
patent: 6903186 (2005-06-01), Dong et al.
patent: 0 733 644 (1996-09-01), None
patent: 2 777 283 (1999-10-01), None
patent: WO91 11457 (1991-08-01), None
patent: WO97 29180 (1997-08-01), None
patent: WO98 08871 (1998-03-01), None
patent: 98/19698 (1998-05-01), None
patent: 99/43705 (1999-09-01), None
patent: 00/34331 (2000-06-01), None
patent: 01/035988 (2001-05-01), None
Mojsov, S. “Structural requirements for biological activity of glucagon-like peptide I,” Int. J. Pep. Prot. Res., 1992, 40:333-343.

Affiliated with

Also associated with

Rating

GLP-1 analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with GLP-1 analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GLP-1 analogues will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3957526